Sickle Cell Treatment Market contains market size and forecasts of Sickle Cell Treatment in Global, including the following market information:
- Global Sickle Cell Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
- Global top five companies in 2021 (%)
The global Sickle Cell Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
- The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
- Blood Transfusion Segment to Reach $ Million by 2028, with a % CAGR in next six years.
- The global key manufacturers of Sickle Cell Treatment include Novartis AG, Global Blood Therapeutics Inc., EMI Holding, Inc., Addmedica Inc., Medunik USA.Inc., Bristol Myers Squibb Co., Baxter Inc., Bluebird Biotechnology and Pfizer Inc., etc. In 2021, the global top five players have a share approximately % in terms of revenue.
- We surveyed the Sickle Cell Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Sickle Cell Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Sickle Cell Treatment Market Segment Percentages, by Type, 2021 (%)
- Blood Transfusion
- Bone Marrow Transplant
- Pharmacotherapy
Global Sickle Cell Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Sickle Cell Treatment Market Segment Percentages, by Application, 2021 (%)
Global Sickle Cell Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Sickle Cell Treatment Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Sickle Cell Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
- Key companies Sickle Cell Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Novartis AG
- Global Blood Therapeutics Inc.
- EMI Holding, Inc.
- Addmedica Inc.
- Medunik USA.Inc.
- Bristol Myers Squibb Co.
- Baxter Inc.
- Bluebird Biotechnology
- Pfizer Inc.
- Eli-Lilly and Co.
- Glycomimetics Inc.
- F.Hoffmann-La Roche
- CRISPR Therapeutics
Industry Market Size
